Aarhus Universitets segl

Alexander Schmitz

Screening for sensitivity towards vincristine and doxorubicin in a newly established B-cell cancer cell line panel revealed great variability in the dose resulting in 50% growth inhibition (GI50)

Publikation: KonferencebidragPosterForskning

Standard

Screening for sensitivity towards vincristine and doxorubicin in a newly established B-cell cancer cell line panel revealed great variability in the dose resulting in 50% growth inhibition (GI50). / Fogd, Kirsten; Bøgsted, Martin; Larsen, Steffen Falgreen et al.
2010. Poster session præsenteret ved Forskningens Dag 2010 - Aalborg Sygehus, Aalborg.

Publikation: KonferencebidragPosterForskning

Harvard

Fogd, K, Bøgsted, M, Larsen, SF, Høholt, H, Jensen, A-M, Madsen, LH, Nyegaard, M, Sørensen, S, Holst, JM, Schmitz, A, Johnsen, HE & Dybkær, K 2010, 'Screening for sensitivity towards vincristine and doxorubicin in a newly established B-cell cancer cell line panel revealed great variability in the dose resulting in 50% growth inhibition (GI50)', Forskningens Dag 2010 - Aalborg Sygehus, Aalborg, 28/10/2010 - 28/10/2010.

APA

Fogd, K., Bøgsted, M., Larsen, S. F., Høholt, H., Jensen, A-M., Madsen, L. H., Nyegaard, M., Sørensen, S., Holst, J. M., Schmitz, A., Johnsen, H. E., & Dybkær, K. (2010). Screening for sensitivity towards vincristine and doxorubicin in a newly established B-cell cancer cell line panel revealed great variability in the dose resulting in 50% growth inhibition (GI50). Poster session præsenteret ved Forskningens Dag 2010 - Aalborg Sygehus, Aalborg.

CBE

Fogd K, Bøgsted M, Larsen SF, Høholt H, Jensen A-M, Madsen LH, Nyegaard M, Sørensen S, Holst JM, Schmitz A, et al. 2010. Screening for sensitivity towards vincristine and doxorubicin in a newly established B-cell cancer cell line panel revealed great variability in the dose resulting in 50% growth inhibition (GI50). Poster session præsenteret ved Forskningens Dag 2010 - Aalborg Sygehus, Aalborg.

MLA

Vancouver

Fogd K, Bøgsted M, Larsen SF, Høholt H, Jensen A-M, Madsen LH et al.. Screening for sensitivity towards vincristine and doxorubicin in a newly established B-cell cancer cell line panel revealed great variability in the dose resulting in 50% growth inhibition (GI50). 2010. Poster session præsenteret ved Forskningens Dag 2010 - Aalborg Sygehus, Aalborg.

Author

Bibtex

@conference{726065515e584f5188ab7cc99cd9ca84,
title = "Screening for sensitivity towards vincristine and doxorubicin in a newly established B-cell cancer cell line panel revealed great variability in the dose resulting in 50% growth inhibition (GI50)",
author = "Kirsten Fogd and Martin B{\o}gsted and Larsen, {Steffen Falgreen} and H H{\o}holt and Ann-Maria Jensen and Madsen, {L H} and Mette Nyegaard and Suzette S{\o}rensen and Holst, {J M} and Alexander Schmitz and Johnsen, {Hans Erik} and Karen Dybk{\ae}r",
year = "2010",
language = "English",
note = "Forskningens Dag 2010 - Aalborg Sygehus ; Conference date: 28-10-2010 Through 28-10-2010",

}

RIS

TY - CONF

T1 - Screening for sensitivity towards vincristine and doxorubicin in a newly established B-cell cancer cell line panel revealed great variability in the dose resulting in 50% growth inhibition (GI50)

AU - Fogd, Kirsten

AU - Bøgsted, Martin

AU - Larsen, Steffen Falgreen

AU - Høholt, H

AU - Jensen, Ann-Maria

AU - Madsen, L H

AU - Nyegaard, Mette

AU - Sørensen, Suzette

AU - Holst, J M

AU - Schmitz, Alexander

AU - Johnsen, Hans Erik

AU - Dybkær, Karen

PY - 2010

Y1 - 2010

M3 - Poster

T2 - Forskningens Dag 2010 - Aalborg Sygehus

Y2 - 28 October 2010 through 28 October 2010

ER -